Biography
Dr Jo Jackson is an Advanced Research Fellow, Alzheimer's Society Dementia Research Leader, the first recipient of the Alzheimer's Society's Carol Jennings Fellowship and an Emerging Leader at the UK DRI at Imperial. Her group takes a multi-‘omic and imaging approach to provide a mechanistic insight into the vulnerability of synaptic components in Alzheimer’s disease. This enables her group to identify and test molecular targets to achieve the vision of therapeutically targeting the synapse in Alzheimer's.
After her PhD at Imperial and post docs at Lund University and Imperial, Jo joined Eli Lilly where she became a team leader leading a research group studying the synapse changes in Alzheimer’s and co-chaired their Neuroplasticity Drug Discovery platform. Since returning to Imperial she has led the £2million Multi-‘omics Atlas Project at the UK DRI at Imperial; an open resource dedicated to the comprehensive, multi-‘omic mapping of the cellular pathology of Alzheimer's. Jo has extensive experience in studying synaptic integration in humans and in animal models of Alzheimer's, axonal injury and epilepsy both in industry and academia.
Jackson Lab
Explore the work of the Jackson Lab focused on investigating vulnerable synaptic components to identify and test molecular targets to therapeutically target the synapse in Alzheimer's
